1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine
1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine (PC(16:0/8:0)) is a phosphatidylcholine glycerophospholipid. 1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine promotes platelet aggregation and flow-induced platelet-dependent thrombus formation. 1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine is a valid biomarker for CAD risk, severity, and subtype differentiation. 1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine is suitable for basic research on various types of coronary artery disease.
For research use only. We do not sell to patients.
- CAS No.: 1070166-56-1
- Formula: C32H64NO8P
- Molecular Weight:621.83
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
In Vitro
1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine (PC(16:0/8:0)) enhances platelet aggregation and promotes flow-dependent, platelet-mediated thrombus formation[1].
1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine (PC(16:0/8:0)) is converted into mature long‑chain phosphatidylcholines through subsequent acyl chain remodeling[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1070166-56-1
-
Molecular Weight 621.83
-
Formula C32H64NO8P
-
SMILES
C[N+](C)(C)CCOP(OC[C@@H](COC(CCCCCCCCCCCCCCC)=O)OC(CCCCCCC)=O)([O-])=O
-
Synonyms
PC(16:0/8:0)
-
Structure Classification
-
Initial Source
Saccharomyces cerevisiae
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- 1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine
- 1070166-56-1
- PC(16:0/8:0)
- Endogenous Metabolite
- acute coronary syndrome
- platelet aggregation
- chronic coronary syndrome
- CAD patients
- coronary artery disease
- healthy individuals
- phosphatidylcholine glycerophospholipid
- platelet-dependent thrombus formation
- human platelets
- healthy controls
- Inhibitor
- inhibitor
- inhibit